SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-030493
Filing Date
2023-06-29
Accepted
2023-06-28 19:50:24
Documents
18
Period of Report
2023-06-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20230627.htm   iXBRL 8-K 73616
2 EX-1.1 axsm-ex1_1.htm EX-1.1 409696
3 EX-5.1 axsm-ex5_1.htm EX-5.1 21921
4 EX-99.1 axsm-ex99_1.htm EX-99.1 15493
5 EX-99.2 axsm-ex99_2.htm EX-99.2 17566
6 GRAPHIC img36028404_0.jpg GRAPHIC 22496
7 GRAPHIC img36951925_0.jpg GRAPHIC 22496
  Complete submission text file 0000950170-23-030493.txt   788695

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axsm-20230627_lab.xml EX-101.LAB 12806
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axsm-20230627_pre.xml EX-101.PRE 9441
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axsm-20230627.xsd EX-101.SCH 2451
12 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20230627_htm.xml XML 4543
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 231053898
SIC: 2834 Pharmaceutical Preparations